Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Zovirax

This article was originally published in The Tan Sheet

Executive Summary

Has been available in Germany for the treatment of cold sores since July 1992 under a marketing agreement between Burroughs Wellcome and Hoechst ("The Tan Sheet" March 8, p. 8). The 5% acyclovir OTC dose in Germany is the same topical dose available as a prescription in the U.S. Zovirax is also marketed over-the- counter in New Zealand, Finland and South Africa, and has been approved for OTC use in Denmark, where it has not yet been launched.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel